Sepsis Diagnostics Market by Technology, Product, Method, Test Type, Pathogen, End-User - Global Forecast to 2023

  • ID: 4497336
  • Report
  • Region: Global
  • 194 Pages
  • Markets and Markets
1 of 4
Global Sepsis Diagnostics Market Projected to Reach USD 613.9 Million by 2023 from USD 396.6 Million in 2018, at a CAGR of 9.1%.

FEATURED COMPANIES

  • Abbott
  • Biomérieux
  • Cytosorbents
  • EKF Diagnostics
  • Luminex
  • T2 Biosystems
  • MORE

"Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), Product (Blood Culture Media, Instruments), Method (Automated), Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End-User - Global Forecast to 2023"

"The sepsis diagnostics market projected to grow at a CAGR of 9.1%."

The global sepsis diagnostics market is projected to reach USD 613.9 million by 2023 from USD 396.6 million in 2018, at a CAGR of 9.1%. Rising incidence of sepsis, rising geriatric population, growing number of surgical procedures, high incidence of hospital-acquired infections, and commercialization and availability of a wide variety of approved sepsis diagnostic devices are the factors expected to drive the market during the study period. However, the lack of established reimbursement policies for sepsis and high cost of automated diagnostic devices are the major factors restraining the growth of this market.

"Microbiology to command the largest share of the sepsis diagnostics market in 2018."

On the basis of technology, the microbiology segment is expected to command the largest share of the global sepsis diagnostics market in 2018. The large share of this segment can be attributed to the growing use of blood culture techniques for the diagnosis of sepsis.

"The blood culture media segment is expected to be the fastest-growing segment during the forecast period."

On the basis of products, the market is segmented into blood culture media, instruments, assays & reagents, and software. The blood culture media segment is expected to be the fastest-growing segment during the forecast period. The large share of this segment can be attributed to the fact that blood culture testing is used as the standard diagnostic method for the diagnosis and identification of sepsis across the globe.
 
"Asia Pacific is expected grow at the highest CAGR during the forecast period."

Geographically, the sepsis diagnostics market is segmented into North America, Europe, Asia Pacific, and RoW. Asia Pacific is expected to register the highest growth rate during the forecast period due to the high prevalence of sepsis, increasing number of surgical procedures, growing number of clinical studies, and developing healthcare infrastructure in this region.

Breakdown of supply-side primary interviews:

  • By Company Type - Tier 1 - 30%, Tier 2 - 55% and Tier 3 - 15%
  • By Designation - C-level - 30%, Director-level - 35%, Others - 35%
  • By Region - North America - 55%, Europe - 15%, APAC - 25%, RoW - 5%

The major players of the sepsis diagnostics market are bioMérieux (France), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), Abbott (US), Roche (Switzerland), Danaher (US), Becton, Dickinson, and Company (US), EKF Diagnostics (UK), Immunexpress (Australia), Response Biomedical (Canada), Axis-Shield Diagnostics (UK), CytoSorbents (US), and Mitsubishi Chemical Europe (Germany).
 
Research Coverage

This report studies the sepsis diagnostics market based on technology, product, pathogen, test type, method, end user, and region. The report studies factors affecting market growth, analyzes opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micromarkets with respect to their individual growth trends. The research report forecasts the revenue of market segments with respect to the four key regions and respective countries.

Reasons to Buy the Report:

From an insights perspective, this research report has focused on various levels of analysis- market ranking analysis of top players and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the sepsis diagnostics market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • Biomérieux
  • Cytosorbents
  • EKF Diagnostics
  • Luminex
  • T2 Biosystems
  • MORE

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
    1.4 Markets Covered
           1.4.1 Years Considered for the Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

2 Research Methodology
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
           2.1.3 Market Size Estimation Methodology
           2.1.4 Bottom-Up Approach
           2.1.5 Top-Down Approach
           2.1.6 Research Design
           2.1.7 Market Data Validation and Triangulation
           2.1.8 Assumptions for the Study

3 Executive Summary

4 Premium Insights
    4.1 Sepsis Diagnostics: Market Overview
    4.2 Sepsis Diagnostic Market, By Technology
    4.3 Geographic Analysis: Sepsis Diagnostics Market, By Product and Region
    4.4 Sepsis Diagnostic Market, By Pathogen
    4.5 Sepsis Diagnostic Market, By Method
    4.6 Geographic Snapshot of the Sepsis Diagnostics Market

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                    5.2.1.1 High Incidence of Sepsis in the Adult Population
                    5.2.1.1 Increasing Incidence of Sepsis in Neonates
                    5.2.1.2 Growing Incidence of Hospital-Acquired Infections
                    5.2.1.3 Increasing Number of Surgical Procedures
                    5.2.1.4 Increasing Burden of Pneumonia
                    5.2.1.5 Influx of Novel Sepsis Diagnostic Products
                    5.2.1.6 Rising Initiatives to Increase the Awareness and Drive the Adoption of Sepsis Diagnostic Tests
                    5.2.1.7 Funding for Sepsis-Related Research Activities
           5.2.2 Restraints
                    5.2.2.1 Lack of Established Reimbursement Policies for Sepsis
                    5.2.2.2 High Cost of Automated Diagnostic Devices
           5.2.3 Opportunities
                    5.2.3.1 Development of Rapid Diagnostic/POC Techniques for Early Sepsis Diagnosis
                    5.2.3.2 Evolution of Novel Biomarkers for Sepsis Diagnosis
           5.2.4 Challenges
                    5.2.4.1 Lack of Standard Protocols and Awareness for Sepsis Diagnosis and Treatment
                    5.2.4.2 Shortage of Skilled Healthcare Professionals

6 Sepsis Diagnostics Market, By Technology
    6.1 Introduction
    6.2 Microbiology
    6.3 Molecular Diagnostics
           6.3.1 Polymerase Chain Reaction
           6.3.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
           6.3.3 Microarrays
           6.3.4 Syndromic Panel-Based Testing
    6.4 Immunoassay
    6.5 Flow Cytometry
    6.6 Microfluidics
    6.7 Biomarkers

7 Sepsis Diagnostics Market, By Product
    7.1 Introduction
    7.2 Instruments
    7.3 Blood Culture Media
    7.4 Assays & Reagents
    7.5 Software

8 Sepsis Diagnostics Market, By Method
    8.1 Introduction
    8.2 Conventional Diagnostics
    8.3 Automated Diagnostics

9 Sepsis Diagnostics Market, By Pathogen
    9.1 Introduction
    9.2 Bacterial Sepsis
           9.2.1 Gram-Negative Bacterial Sepsis
           9.2.2 Gram-Positive Bacterial Sepsis
    9.3 Fungal Sepsis
    9.4 Other Pathogens

10 Sepsis Diagnostics Market, By Test Type
     10.1 Introduction
     10.2 Laboratory Tests
     10.3 Point-Of-Care Tests

11 Sepsis Diagnostics Market, By End User
     11.1 Introduction
     11.2 Hospitals
     11.3 Pathology & Reference Laboratories

12 Sepsis Diagnostics Market, By Region
     12.1 Introduction
     12.2 North America
             12.2.1 US
             12.2.2 Canada
     12.3 Europe
             12.3.1 Germany
             12.3.2 France
             12.3.3 UK
             12.3.4 Rest of Europe (RoE)
     12.4 Asia Pacific
             12.4.1 Japan
             12.4.2 China
             12.4.3 India
             12.4.4 Rest of Asia Pacific
     12.5 Rest of the World
             12.5.1 Latin America
             12.5.2 Middle East & Africa

13 Competitive Landscape
     13.1 Overview
     13.2 Market Share Analysis
     13.3 Competitive Scenario
             13.3.1 Product Launches and Approvals, 2015-2017
             13.3.2 Partnerships and Collaborations, 2015-2018
             13.3.3 Mergers and Acquisitions

14 Company Profiles
(Business Overview, Products Offered, Recent Developments, View)*
     14.1 Biomérieux
     14.2 T2 Biosystems
     14.3 Luminex
     14.4 Becton, Dickinson, and Company (BD)
     14.5 Roche Diagnostics (A Subsidiary of F. Hoffmann-LA Roche Ltd.)
     14.6 Danaher
     14.7 Thermo Fisher Scientific
     14.8 Bruker
     14.9 Abbott
     14.10 Immunexpress
     14.11 Response Biomedical
     14.12 Axis-Shield Diagnostics
     14.13 Cytosorbents
     14.14 Mitsubishi Chemical Europe
     14.15 EKF Diagnostics

*Business Overview, Products Offered, Recent Developments, View Might Not Be Captured in Case of Unlisted Companies.

List of Tables
Table 1 Sepsis Diagnostics Market, By Technology, 2016-2023 (USD Million)
Table 2 Microbiology Market for Sepsis Diagnosis, By Region, 2016-2023 (USD Million)
Table 3 Molecular Diagnostics Market for Sepsis Diagnosis, By Region, 2016-2023 (USD Million)
Table 4 Immunoassay Market for Sepsis Diagnosis, By Region, 2016-2023 (USD Million)
Table 5 Flow Cytometry Market for Sepsis Diagnosis, By Region, 2016-2023 (USD Million)
Table 6 Microfluidics Market for Sepsis Diagnosis, By Region, 2016-2023 (USD Million)
Table 7 Biomarkers Market for Sepsis Diagnosis, By Region, 2016-2023 (USD Million)
Table 8 Sepsis Diagnostic Market, By Product, 2016-2023 (USD Million)
Table 9 Sepsis Diagnostic Instruments Market, By Region, 2016-2023 (USD Million)
Table 10 Sepsis Diagnostic Blood Culture Media Market, By Region, 2016-2023 (USD Million)
Table 11 Sepsis Diagnostic Assays & Reagents Market, By Region, 2016-2023 (USD Million)
Table 12 Sepsis Diagnostic Software Market, By Region, 2016-2023 (USD Million)
Table 13 Sepsis Diagnostics Market, By Method, 2016-2023 (USD Million)
Table 14 Conventional Diagnostics Market, By Region, 2016-2023 (USD Million)
Table 15 Automated Diagnostics Market, By Region, 2016-2023 (USD Million)
Table 16 Sepsis Diagnostic Market, By Pathogen, 2016-2023 (USD Million)
Table 17 Bacterial Sepsis Market, By Type, 2016-2023 (USD Million)
Table 18 Bacterial Sepsis Market, By Region, 2016-2023 (USD Million)
Table 19 Bacterial Causes of Adult Sepsis
Table 20 Bacterial Causes of Adult Sepsis
Table 21 Fungal Sepsis Market, By Region, 2016-2023 (USD Million)
Table 22 Other Pathogens Market, By Region, 2016-2023 (USD Million)
Table 23 Sepsis Diagnostics Market, By Test Type, 2016-2023 (USD Million)
Table 24 Laboratory Pointers of Sepsis
Table 25 Laboratory Tests Market, By Region, 2016-2023 (USD Million)
Table 26 Point-Of-Care Tests Market, By Region, 2016-2023 (USD Million)
Table 27 Sepsis Diagnostics Market, By End User, 2016-2023 (USD Million)
Table 28 Sepsis Diagnostic Market for Hospitals, By Region, 2016-2023 (USD Million)
Table 29 Sepsis Diagnostics Market for Pathology & Reference Laboratories, By Region, 2016-2023 (USD Million)
Table 30 Sepsis Diagnostic Market, By Region, 2016-2023 (USD Million)
Table 31 North America: Sepsis Diagnostics Market, By Country, 2016-2023 (USD Million)
Table 32 North America: Sepsis Diagnostic Market, By Technology, 2016-2023 (USD Million)
Table 33 North America: Sepsis Diagnostics Market, By Product, 2016-2023 (USD Million)
Table 34 North America: Sepsis Diagnostic Market, By Pathogen, 2016-2023 (USD Million)
Table 35 North America: Sepsis Diagnostics Market, By Method, 2016-2023 (USD Million)
Table 36 North America: Sepsis Diagnostics Market, By Test Type, 2016-2023 (USD Million)
Table 37 North America: Sepsis Diagnostics Market, By End User, 2016-2023 (USD Million)
Table 38 US: Sepsis Diagnostic Market, By Technology, 2016-2023 (USD Million)
Table 39 US: Sepsis Diagnostics Market, By Product, 2016-2023 (USD Million)
Table 40 US: Sepsis Diagnostic Market, By Pathogen, 2016-2023 (USD Million)
Table 41 US: Sepsis Diagnostics Market, By Method, 2016-2023 (USD Million)
Table 42 US: Sepsis Diagnostic Market, By Test Type, 2016-2023 (USD Million)
Table 43 US: Sepsis Diagnostics Market, By End User, 2016-2023 (USD Million)
Table 44 Canada: Sepsis Diagnostic Market, By Technology, 2016-2023 (USD Million)
Table 45 Canada: Sepsis Diagnostics Market, By Product, 2016-2023 (USD Million)
Table 46 Canada: Sepsis Diagnostic Market, By Pathogen, 2016-2023 (USD Million)
Table 47 Canada: Sepsis Diagnostics Market, By Method, 2016-2023 (USD Million)
Table 48 Canada: Sepsis Diagnostic Market, By Test Type, 2016-2023 (USD Million)
Table 49 Canada: Sepsis Diagnostics Market, By End User, 2016-2023 (USD Million)
Table 50 Europe: Sepsis Diagnostic Market, By Country, 2016-2023 (USD Million)
Table 51 Europe: Sepsis Diagnostics Market, By Technology, 2016-2023 (USD Million)
Table 52 Europe: Sepsis Diagnostic Market, By Product, 2016-2023 (USD Million)
Table 53 Europe: Sepsis Diagnostics Market, By Pathogen, 2016-2023 (USD Million)
Table 54 Europe: Sepsis Diagnostic Market, By Method, 2016-2023 (USD Million)
Table 55 Europe: Sepsis Diagnostics Market, By Test Type, 2016-2023 (USD Million)
Table 56 Europe: Sepsis Diagnostic Market, By End User, 2016-2023 (USD Million)
Table 57 Germany: Sepsis Diagnostics Market, By Technology, 2016-2023 (USD Million)
Table 58 Germany: Sepsis Diagnostic Market, By Product, 2016-2023 (USD Million)
Table 59 Germany: Sepsis Diagnostics Market, By Pathogen, 2016-2023 (USD Million)
Table 60 Germany: Sepsis Diagnostic Market, By Method, 2016-2023 (USD Million)
Table 61 Germany: Sepsis Diagnostics Market, By Test Type, 2016-2023 (USD Million)
Table 62 Germany: Sepsis Diagnostic Market, By End User, 2016-2023 (USD Million)
Table 63 France: Sepsis Diagnostics Market, By Technology, 2016-2023 (USD Million)
Table 64 France: Sepsis Diagnostic Market, By Product, 2016-2023 (USD Million)
Table 65 France: Sepsis Diagnostics Market, By Pathogen, 2016-2023 (USD Million)
Table 66 France: Sepsis Diagnostic Market, By Method, 2016-2023 (USD Million)
Table 67 France: Sepsis Diagnostics Market, By Test Type, 2016-2023 (USD Million)
Table 68 France: Sepsis Diagnostic Market, By End User, 2016-2023 (USD Million)
Table 69 UK: Sepsis Diagnostics Market, By Technology, 2016-2023 (USD Million)
Table 70 UK: Sepsis Diagnostic Market, By Product, 2016-2023 (USD Million)
Table 71 UK: Sepsis Diagnostics Market, By Pathogen, 2016-2023 (USD Million)
Table 72 UK: Sepsis Diagnostic Market, By Method, 2016-2023 (USD Million)
Table 73 UK: Sepsis Diagnostics Market, By Test Type, 2016-2023 (USD Million)
Table 74 UK: Sepsis Diagnostic Market, By End User, 2016-2023 (USD Million)
Table 75 RoE: Sepsis Diagnostics Market, By Technology, 2016-2023 (USD Million)
Table 76 RoE: Sepsis Diagnostic Market, By Product, 2016-2023 (USD Million)
Table 77 RoE: Sepsis Diagnostics Market, By Pathogen, 2016-2023 (USD Million)
Table 78 RoE: Sepsis Diagnostic Market, By Method, 2016-2023 (USD Million)
Table 79 RoE: Sepsis Diagnostics Market, By Test Type, 2016-2023 (USD Million)
Table 80 RoE: Sepsis Diagnostic Market, By End User, 2016-2023 (USD Million)
Table 81 APAC: Sepsis Diagnostics Market, By Country, 2016-2023 (USD Million)
Table 82 APAC: Sepsis Diagnostic Market, By Technology, 2016-2023 (USD Million)
Table 83 APAC: Sepsis Diagnostics Market, By Product, 2016-2023 (USD Million)
Table 84 APAC: Sepsis Diagnostic Market, By Pathogen, 2016-2023 (USD Million)
Table 85 APAC: Sepsis Diagnostics Market, By Method, 2016-2023 (USD Million)
Table 86 APAC: Sepsis Diagnostic Market, By Test Type, 2016-2023 (USD Million)
Table 87 APAC: Sepsis Diagnostics Market, By End User, 2016-2023 (USD Million)
Table 88 Japan: Sepsis Diagnostic Market, By Technology, 2016-2023 (USD Million)
Table 89 Japan: Sepsis Diagnostics Market, By Product, 2016-2023 (USD Million)
Table 90 Japan: Sepsis Diagnostic Market, By Pathogen, 2016-2023 (USD Million)
Table 91 Japan: Sepsis Diagnostics Market, By Method, 2016-2023 (USD Million)
Table 92 Japan: Sepsis Diagnostic Market, By Test Type, 2016-2023 (USD Million)
Table 93 Japan: Sepsis Diagnostics Market, By End User, 2016-2023 (USD Million)
Table 94 China: Sepsis Diagnostic Market, By Technology, 2016-2023 (USD Million)
Table 95 China: Sepsis Diagnostics Market, By Product, 2016-2023 (USD Million)
Table 96 China: Sepsis Diagnostic Market, By Pathogen, 2016-2023 (USD Million)
Table 97 China: Sepsis Diagnostics Market, By Method, 2016-2023 (USD Million)
Table 98 China: Sepsis Diagnostic Market, By Test Type, 2016-2023 (USD Million)
Table 99 China: Sepsis Diagnostics Market, By End User, 2016-2023 (USD Million)
Table 100 India: Sepsis Diagnostic Market, By Technology, 2016-2023 (USD Million)
Table 101 India: Sepsis Diagnostics Market, By Product, 2016-2023 (USD Million)
Table 102 India: Sepsis Diagnostic Market, By Pathogen, 2016-2023 (USD Million)
Table 103 India: Sepsis Diagnostics Market, By Method, 2016-2023 (USD Million)
Table 104 India: Sepsis Diagnostic Market, By Test Type, 2016-2023 (USD Million)
Table 105 India: Sepsis Diagnostics Market, By End User, 2016-2023 (USD Million)
Table 106 RoAPAC: Sepsis Diagnostics Market, By Technology, 2016-2023 (USD Million)
Table 107 RoAPAC: Sepsis Diagnostics Market, By Product, 2016-2023 (USD Million)
Table 108 RoAPAC: Sepsis Diagnostic Market, By Pathogen, 2016-2023 (USD Million)
Table 109 RoAPAC: Sepsis Diagnostics Market, By Method, 2016-2023 (USD Million)
Table 110 RoAPAC: Sepsis Diagnostics Market, By Test Type, 2016-2023 (USD Million)
Table 111 RoAPAC: Sepsis Diagnostic Market, By End User, 2016-2023 (USD Million)
Table 112 RoW: Sepsis Diagnostics Market, By Region, 2016-2023 (USD Million)
Table 113 RoW: Sepsis Diagnostics Market, By Technology, 2016-2023 (USD Million)
Table 114 RoW: Sepsis Diagnostic Market, By Product, 2016-2023 (USD Million)
Table 115 RoW: Sepsis Diagnostics Market, By Pathogen, 2016-2023 (USD Million)
Table 116 RoW: Sepsis Diagnostic Market, By Method, 2016-2023 (USD Million)
Table 117 RoW: Sepsis Diagnostics Market, By Test Type, 2016-2023 (USD Million)
Table 118 RoW: Sepsis Diagnostic Market, By End User, 2016-2023 (USD Million)
Table 119 Latin America: Sepsis Diagnostics Market, By Technology, 2016-2023 (USD Million)
Table 120 Latin America: Sepsis Diagnostic Market, By Product, 2016-2023 (USD Million)
Table 121 Latin America: Sepsis Diagnostics Market, By Pathogen, 2016-2023 (USD Million)
Table 122 Latin America: Sepsis Diagnostic Market, By Method, 2016-2023 (USD Million)
Table 123 Latin America: Sepsis Diagnostics Market, By Test Type, 2016-2023 (USD Million)
Table 124 Latin America: Sepsis Diagnostic Market, By End User, 2016-2023 (USD Million)
Table 125 Middle East & Africa: Sepsis Diagnostics Market, By Technology, 2016-2023 (USD Million)
Table 126 Middle East & Africa: Sepsis Diagnostics Market, By Product, 2016-2023 (USD Million)
Table 127 Middle East & Africa: Sepsis Diagnostic Market, By Pathogen, 2016-2023 (USD Million)
Table 128 Middle East & Africa: Sepsis Diagnostics Market, By Method, 2016-2023 (USD Million)
Table 129 Middle East & Africa: Sepsis Diagnostic Market, By Test Type, 2016-2023 (USD Million)
Table 130 Middle East & Africa: Sepsis Diagnostics Market, By End User, 2016-2023 (USD Million)

List of Figures
Figure 1 Global Sepsis Diagnostics Market: Research Methodology Steps
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Data Triangulation Methodology
Figure 4 Global Sepsis Diagnostic Market, By Product, 2018
Figure 5 Global Sepsis Diagnostics Market, By Technology, 2023
Figure 6 Global Sepsis Diagnostic Market, By Method, 2018
Figure 7 Global Sepsis Diagnostic Market, By Test Type, 2018 vs 2023
Figure 8 Global Sepsis Diagnostics Market, By Pathogen, 2018
Figure 9 Global Sepsis Diagnostics Market, By End User, 2018
Figure 10 Global Sepsis Diagnostics Market, By Region, 2018 (USD Million)
Figure 11 Rising Prevalence of Sepsis is Driving the Growth of Sepsis Diagnostics Market Across the Globe
Figure 12 Microbiology Segment Will Continue to Dominate the Market in 2023
Figure 13 Blood Culture Media Segment to Dominate the Global Sepsis Diagnostics Products Market in 2018
Figure 14 Bacterial Sepsis Segment to Dominate the Sepsis Diagnostic Market During the Forecast Period
Figure 15 Conventional Diagnostics Method to Dominate the Sepsis Diagnostics Market During the Forecast Period
Figure 16 Asia Pacific to Register the Highest CAGR During the Forecast Period
Figure 17 Sepsis Diagnostic Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Biomarkers Segment to Witness the Highest Growth During the Forecast Period
Figure 19 Blood Culture Media Segment to Witness Highest Growth During the Forecast Period
Figure 20 Conventional Diagnostics Segment to Dominate the Sepsis Diagnostics Market in 2023
Figure 21 Bacterial Sepsis Segment to Register the Highest Growth Rate During the Forecast Period
Figure 22 Point-Of-Care Tests Segment to Grow at the Highest CAGR
Figure 23 Hospitals Segment to Dominate the Sepsis Diagnostics Market in 2023
Figure 24 Sepsis Incidence, By Country, 2017
Figure 25 Sepsis Diagnostic Market: Growth Forecast, By Region (2018-2023)
Figure 26 North America: Sepsis Diagnostics Market Snapshot
Figure 27 Europe: Sepsis Diagnostic Market Snapshot
Figure 28 APAC: Sepsis Diagnostic Market Snapshot
Figure 29 Key Developments By Leading Market Players in the Sepsis Diagnostics Market, 2015-2017
Figure 30 Sepsis Diagnostics Market Share, By Key Players, 2016
Figure 31 Biomérieux: Company Snapshot
Figure 32 T2 Biosystems: Company Snapshot
Figure 33 Luminex: Company Snapshot
Figure 34 BD: Company Snapshot
Figure 35 Roche Diagnostics: Company Snapshot
Figure 36 Danaher: Company Snapshot
Figure 37 Thermo Fisher Scientific: Company Snapshot
Figure 38 Bruker: Company Snapshot
Figure 39 Abbott: Company Snapshot
Figure 40 Cytosorbents: Company Snapshot
Figure 41 EKF Diagnostics: Company Snapshot

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Abbott
  • Biomérieux
  • Cytosorbents
  • EKF Diagnostics
  • Luminex
  • T2 Biosystems
  • MORE

The global sepsis diagnostic market is projected to reach USD 613.9 Million by 2023 from USD 396.6 Million in 2018, at a CAGR of 9.1% during the forecast period. Factors such as rising prevalence of sepsis across the globe, increasing geriatric population, growing government initiatives for creating sepsis awareness, and high incidence of hospital-acquired infections are expected to drive the demand for sepsis diagnosis during the study period.

This report broadly segments the sepsis diagnostics market into technology, product, pathogen, method, test type, end user, and region.

On the basis of technology, the market is segmented into microbiology, immunoassays, molecular diagnostics, flow cytometry, microfluidics, and biomarkers. In 2017, the microbiology segment accounted for the largest share of the sepsis diagnostic market. This share can be attributed to the low cost of microbiology techniques and the wide use of blood culture methods for the diagnosis of sepsis.

On the basis of products, the global sepsis diagnostics market is segmented into blood culture media, assays & reagents, instruments, and software. The blood culture media segment is estimated to command the largest share of the global sepsis diagnostics market in 2018. The large share of this segment can be attributed to the increasing use of blood culture testing as the standard diagnostic method for the diagnosis and identification of sepsis.

On the basis of methods, the sepsis diagnostic market is categorized into two segments, namely, conventional diagnostics and automated diagnostics. The automated diagnostics segment is expected to grow at the highest CAGR from 2018 to 2023. Accurate detection of positive blood cultures, quick turnaround time, and reduced risk of contamination is contributing to the growth of this segment.

On the basis of test type, the sepsis diagnostics market is further segmented into laboratory tests and point-of-care tests. The laboratory tests segment is estimated to account for the largest share of the sepsis diagnostic market in 2018. The large share of this segment can be attributed to the high use of conventional blood culture tests for sepsis diagnosis, lack of awareness about POC sepsis diagnostic tests, and low cost of laboratory testing services.

The sepsis diagnostics market on the basis of pathogens is segmented into bacterial sepsis, fungal sepsis, and other infectious pathogens (viral and parasitic infection). The bacterial sepsis segment is expected to account for the largest share of the sepsis diagnostic market during the forecast period. The large share of this segment can be attributed to the growing number of bacterial sepsis cases and increasing number of surgical procedures.

The sepsis diagnostics market on the basis of end user is segmented into hospitals and pathology & reference laboratories. The hospitals segment is estimated to account for the largest share of the sepsis diagnostic market in 2018. The large share of this segment can be attributed to the rising number of initiatives taken by hospitals for sepsis diagnosis coupled with the prevalence of sepsis across the globe.

Sepsis Diagnostics Market

The report covers the sepsis diagnostics market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to command the largest share of the market in 2018, due to the growing prevalence of sepsis, fast adoption of high-end sepsis diagnostics devices, and rising government support for sepsis-related research.

The major players of the market are bioMérieux (France), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US), Abbott (US), Roche (Switzerland), Danaher (US), Becton, Dickinson, and Company (US), EKF Diagnostics (UK), Immunexpress (Australia), Response Biomedical (Canada), Axis-Shield Diagnostics (UK), CytoSorbents (US), and Mitsubishi Chemical Europe (Germany).

Note: Product cover images may vary from those shown
5 of 4
  • Abbott
  • Axis-Shield Diagnostics
  • Becton, Dickinson, and Company (BD)
  • Biomérieux
  • Bruker
  • Cytosorbents
  • Danaher
  • EKF Diagnostics
  • Immunexpress
  • Luminex
  • Mitsubishi Chemical Europe
  • Response Biomedical
  • Roche Diagnostics (A Subsidiary of F. Hoffmann-LA Roche Ltd.)
  • T2 Biosystems
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
6 of 4
Note: Product cover images may vary from those shown
Adroll
adroll